M34-47339-89832
3 vaccinations
2 coded responses
38 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 200 / DC
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Registered in v-safe
-
2021-04-01
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-01
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-02
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-03
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-06
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-07-01
- 2021-09-30
-
2021-10-27
Dose 2 — Moderna
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-11
- 2021-11-17
- 2021-11-24
- 2021-12-01
- 2021-12-08
- 2022-01-26
- 2022-04-27
-
2022-05-08
Dose 3 — Moderna
-
2022-05-11
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling, Itching · NoneAdult check-in
- 2022-05-12
-
2022-05-13
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Headache, Muscle or body aches, Nausea · Be unable to work or attend schoolAdult check-in
- 2022-05-14
- 2022-05-15
- 2022-05-22
- 2022-05-29
- 2022-06-05
- 2022-06-12
- 2022-06-19
-
2022-08-07
Survey response — 3 months, dose 3MedDRA: COVID-19, Fatigue, Headache, Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Headache, sore throat, congestion, fatigue. I had COVID.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-07
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-08-08
-
2022-11-07
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: ColdMedDRA releases: 2024-11 · check-in free text available
- 2023-05-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-27 | Moderna | No |
| 3 | 2022-05-08 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 — 3 months, dose 3
Symptoms: Headache, sore throat, congestion, fatigue. I had COVID.
Release 12 — 6 months, dose 3
Symptoms: Cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release